• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

67
22
14
14
10

COUNTRY

7
6
4
3
3

PRICE

86
114
147
237

PUBLISHED

4
5
24
237

PRODUCT TYPE

209
24
3
1

Drug Discovery

Bringing a new medicine to market is a process that cost about $1bn and can take up to 15 years. With the pharmaceutical industry facing multiple crises, budgets for research being squeezed and tough scientific challenges looming, academics and patients' groups are concerned we will not have the drugs necessary to treat future ills. More challenges will be posed by the imminent expiry of patents for some of the most lucrative drugs. The old model of drug discovery seems to be no longer efficient.

What is the future scenario of R&D? Keep track of the latest developments, trends and issues in this crucial sector of the huge pharmaceuticals industry with the publications listed under Research and Markets’ Drug Discovery category. You will find a wide range of academic and scientific textbooks on the latest R&D techniques, as well as top quality market reports with historical data and forecasts. Show Less
Read more

PRODUCT TITLE
Metabolic Syndrome Metabolic Syndrome - Product Thumbnail Image

Metabolic Syndrome

The increasing worldwide prevalence of metabolic syndrome represents an important healthcare issue across the world Metabolic syndrome is most frequently defined by a presence of certain traits, including...

December 2010
FROM
Dried Blood Spots Part 2 Dried Blood Spots Part 2 - Product Thumbnail Image

Dried Blood Spots Part 2

Dried blood spot (DBS) sampling involves spotting blood from a heel- or finger-prick onto a card which is then air dried and sealed in bags with desiccant for storage and shipping The technique offers...

November 2010
FROM
Global Biosimilars (Follow-on biologics) Market: An Analysis Global Biosimilars (Follow-on biologics) Market: An Analysis - Product Thumbnail Image

Global Biosimilars (Follow-on biologics) Market: An Analysis

Biosimilars or FOBs (Follow-on biologics) refer to generic versions of patented branded biological drugs, developed subsequent to the patent expiry of brand name products The biosimilars market is segmented...

November 2010
FROM
Personalized Medicine Personalized Medicine - Product Thumbnail Image

Personalized Medicine

The right drug for the right patient at the right time for the right period of time is the basic premise of personalized medicine Personalized medicine has the potential of narrowing this gap in drug...

November 2010
FROM
Multiple Sclerosis Drug Discoveries - What the Future Holds Multiple Sclerosis Drug Discoveries - What the Future Holds - Product Thumbnail Image

Multiple Sclerosis Drug Discoveries - What the Future Holds

The recent approval in the US of Novartis' orally administered Gilenya (fingolimod) heralds a new phase in the treatment of Multiple Sclerosis (MS) Over the last few years, the MS market has been driven...

October 2010
FROM
Biomarker Research in Parkinson's Disease Biomarker Research in Parkinson's Disease - Product Thumbnail Image

Biomarker Research in Parkinson's Disease

The concept of 'personalized medicine' has reached the forefront of neurodegenerative diseases There is a need for objective markers of Parkinson's disease that can indicate the biological processes...

October 2010
FROM
Drug Discovery Outsourcing Market in China Drug Discovery Outsourcing Market in China - Product Thumbnail Image

Drug Discovery Outsourcing Market in China

This Market Engineering research service has been developed to address the dynamics of Drug Discovery in China The market covers four main area, that is gene sequencing, target ID, target validation...

September 2010
FROM
MRSA Drug Futures MRSA Drug Futures - Product Thumbnail Image

MRSA Drug Futures

MRSA: a complex issue MRSA infection - especially the hospital acquired variety - has been front page news for some years, but reports of falling rates of infection in the US and Europe masks the real...

September 2010
FROM
Dried Blood Spots Part 1 Dried Blood Spots Part 1 - Product Thumbnail Image

Dried Blood Spots Part 1

Dried blood spot (DBS) sampling involves spotting blood from a heel- or finger-prick onto a card which is then air dried and sealed in bags with desiccant for storage and shipping The technique offers...

August 2010
FROM
MIST - Metabolites in Safety Testing MIST - Metabolites in Safety Testing - Product Thumbnail Image

MIST - Metabolites in Safety Testing

Regulatory guidelines on metabolites in safety testing (MIST) were initially established in 2005 following intense discussions between industry and the US FDA The guidelines were finalized in 2008,...

July 2010
FROM
Competitor Analysis: Cytomegalovirus (CMV) Vaccines and Therapeutics Competitor Analysis: Cytomegalovirus (CMV) Vaccines and Therapeutics - Product Thumbnail Image

Competitor Analysis: Cytomegalovirus (CMV) Vaccines and Therapeutics

The present Competitive Intelligence Report about CMV Vaccines & Therapeutics provides a competitor evaluation in the field of prophylactic vaccines and therapeutic antibodies, antisense, peptides,...

June 2010
FROM

Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, 4th Edition

Kalorama Information's Outsourcing in Drug Discovery offers unparalleled discussion of the drug discovery outsourcing market. It presents viewpoints from both customers and suppliers. Segments, size,...

June 2010
FROM
Ion Channels: Key Therapeutic Targets Ion Channels: Key Therapeutic Targets - Product Thumbnail Image

Ion Channels: Key Therapeutic Targets

This Special Focus Issue of the peer-reviewed journal Future Medicinal Chemistry provides a comprehensive, forward-looking overview of topical themes and recent advances in the field of ion channel-based...

May 2010
FROM
The Contract Research Market for Drug Discovery Technologies: Opportunities for Life Science Suppliers The Contract Research Market for Drug Discovery Technologies: Opportunities for Life Science Suppliers - Product Thumbnail Image

The Contract Research Market for Drug Discovery Technologies: Opportunities for Life Science Suppliers

In recent years, industrial and pharmaceutical companies have increased the amount of services they outsource to contract research organizations (CROs) This report will address whether CROs that service...

April 2010
FROM
Microdosing: Special Focus Microdosing: Special Focus - Product Thumbnail Image

Microdosing: Special Focus

This Special Focus Issue of the peer-reviewed journal Bioanalysis on microdosing collates data and experience of experts and thought leaders in the field of drug discovery and development and places...

March 2010
FROM

Lab Automation Markets, 2nd Edition (Systems, Key Companies, Forecasts and Trends)

This report, Lab Automation Markets analyzes the current and potential world markets for medical laboratory automation systems and equipment - both for clinical diagnostics and drug discovery research...

March 2010
FROM

Radio Frequency Identification (RFID) in Pharmaceuticals - Supply Chain Security Concerns Provide Impetus for RFID Adoption

“Radio Frequency Identification (RFID) in Pharmaceuticals - Supply Chain Security Concerns Provides Impetus for RFID Adoption ” provides key data and analysis of the major factors affecting the market...

February 2010
FROM

Biomarkers in Drug Discovery - Optimizing Drug Discovery Timeline and Costs

“Biomarkers In Drug Discovery - Optimizing Drug Discovery Timeline and Costs” The report provides an in-depth analysis of the potential applications of biomarkers in pharmaceutical drug discovery and...

February 2010
FROM
Orphan Drugs in Asia-Pacific: From Designation to Pricing, Funding & Market Access Orphan Drugs in Asia-Pacific: From Designation to Pricing, Funding & Market Access - Product Thumbnail Image Special Offer Sale Banner

Orphan Drugs in Asia-Pacific: From Designation to Pricing, Funding & Market Access

A major new report Orphan Drugs in Asia-Pacific: From designation to pricing, funding and market access focuses on five developed markets in the region: Japan, South Korea, Taiwan, Singapore and Australia...

February 2010

Drug Discovery in India and China - Gaining Momentum with Increasing Pressure on Cost Cutting

“Drug Discovery in India and China - Gaining Momentum with Increasing Pressure on Cost Cutting ” provides key data, information and analysis of the major trends and issues affecting the drug discovery...

February 2010
FROM
Loading Indicator

Our Clients

Pfizer, Inc. CSL Limited Novartis AG Qiagen N.V. Quintiles Transnational Roche Diagnostics Ltd.